![NICE's thumbs-up on Lilly's migraine med Emgality leaves rivals from Novartis and Teva in the dust | Fierce Pharma NICE's thumbs-up on Lilly's migraine med Emgality leaves rivals from Novartis and Teva in the dust | Fierce Pharma](https://qtxasset.com/cdn-cgi/image/w=384,h=216,f=auto,fit=crop,g=0.5x0.5/https://qtxasset.com/quartz/qcloud5/media/image/fiercepharma/1605712597/emgality.jpg/emgality.jpg?VersionId=s53qa5HDrYH1evXCzU6Ui_OIvBCIl4dP)
NICE's thumbs-up on Lilly's migraine med Emgality leaves rivals from Novartis and Teva in the dust | Fierce Pharma
![Teva Pharmaceuticals on X: "Migraine is not just a headache. Our migraine expert, Dr Joshua Cohen, explains why it's time to break the stigma. #MigraineandHeadacheAwarenessMonth https://t.co/rD3hXiRVoc https://t.co/b46jYhpZSH" / X Teva Pharmaceuticals on X: "Migraine is not just a headache. Our migraine expert, Dr Joshua Cohen, explains why it's time to break the stigma. #MigraineandHeadacheAwarenessMonth https://t.co/rD3hXiRVoc https://t.co/b46jYhpZSH" / X](https://pbs.twimg.com/media/EbrnSX8X0AMJXTD.jpg)
Teva Pharmaceuticals on X: "Migraine is not just a headache. Our migraine expert, Dr Joshua Cohen, explains why it's time to break the stigma. #MigraineandHeadacheAwarenessMonth https://t.co/rD3hXiRVoc https://t.co/b46jYhpZSH" / X
![Teva launches AJOVY for the treatment of migraine with the YpsoMate autoinjector from Ypsomed - Ypsomed - Group Teva launches AJOVY for the treatment of migraine with the YpsoMate autoinjector from Ypsomed - Ypsomed - Group](https://www.ypsomed.com/files/media/02_Images/09_Press_Releases/Ajovy_Pen_CMYK_DE_ohneSchatten_low.png)
Teva launches AJOVY for the treatment of migraine with the YpsoMate autoinjector from Ypsomed - Ypsomed - Group
![Ontario, British Columbia, Nova Scotia, New Brunswick, and Newfoundland, join a growing list of provinces providing public drug plan reimbursement for Teva Canada's AJOVY® (fremanezumab), for the preventive treatment of migraine in Ontario, British Columbia, Nova Scotia, New Brunswick, and Newfoundland, join a growing list of provinces providing public drug plan reimbursement for Teva Canada's AJOVY® (fremanezumab), for the preventive treatment of migraine in](https://mma.prnewswire.com/media/1817134/Teva_Canada_Ontario__British_Columbia__Nova_Scotia__New_Brunswic.jpg?p=facebook)
Ontario, British Columbia, Nova Scotia, New Brunswick, and Newfoundland, join a growing list of provinces providing public drug plan reimbursement for Teva Canada's AJOVY® (fremanezumab), for the preventive treatment of migraine in
![Teva Canada Announces New Autoinjector for AJOVY® for the Preventive Treatment of Migraine in Adults | Business Wire Teva Canada Announces New Autoinjector for AJOVY® for the Preventive Treatment of Migraine in Adults | Business Wire](https://mms.businesswire.com/media/20210408005437/en/868792/5/Teva_Canada_-_AJOVY_Autoinjector.jpg)
Teva Canada Announces New Autoinjector for AJOVY® for the Preventive Treatment of Migraine in Adults | Business Wire
![Teva Preps FDA Filing after Positive Phase III Data for Migraine Drug - Drug Discovery and Development Teva Preps FDA Filing after Positive Phase III Data for Migraine Drug - Drug Discovery and Development](https://drugdiscoverytrends.com/wp-content/uploads/2019/10/ddd1706_migraine.jpg)
Teva Preps FDA Filing after Positive Phase III Data for Migraine Drug - Drug Discovery and Development
![Areas of care treated by Teva. (Sources: 1 Teva treatment for migraine,... | Download Scientific Diagram Areas of care treated by Teva. (Sources: 1 Teva treatment for migraine,... | Download Scientific Diagram](https://www.researchgate.net/publication/352379014/figure/fig1/AS:1034589430611970@1623676750101/Areas-of-care-treated-by-Teva-Sources-1-Teva-treatment-for-migraine.png)